HOME >> MEDICINE >> NEWS
Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer

Preliminary results from a large, randomized clinical trial for patients with previously untreated advanced non-squamous, non-small cell lung cancer show that those patients who received bevacizumab (AvastinTM) in combination with standard chemotherapy lived longer than patients who received the same chemotherapy without bevacizumab.

The clinical trial was sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and conducted by a network of researchers led by the Eastern Cooperative Oncology Group. Genentech, Inc., South San Francisco, Calif., which manufactures bevacizumab, provided bevacizumab for the trial under the Cooperative Research and Development Agreement (CRADA) with NCI for the clinical development of bevacizumab.

The Data Monitoring Committee overseeing the trial (known as E4599)* recommended that the results of a recent interim analysis be made public because the study had met its primary endpoint of improving overall survival. Researchers found that patients in the study who received bevacizumab in combination with standard chemotherapy (a treatment regimen of paclitaxel and carboplatin) had a median overall survival of 12.5 months compared to patients treated with the standard chemotherapy alone, who had a median survival of 10.2 months. This difference is statistically significant. Detailed results from this trial will be presented at the American Society of Clinical Oncology Annual Meeting (ASCO) to be held in Orlando, Fla., on May 13-17, 2005.

"The exciting results of this randomized study reveal, for the first time, an improvement in survival with the addition of a targeted agent to standard chemotherapy in this patient population," said Study Chair Alan B. Sandler, M.D., of the Vanderbilt University Medical Center in Nashville, Tenn.

"This study demonstrates that mechanistic-based interventions such as angiogenesis inhibitors are making important contribution
'"/>

Contact: NCI Press Officers
ncipressofficers@mail.nih.gov
301-496-6641
NIH/National Cancer Institute
14-Mar-2005


Page: 1 2 3

Related medicine news :

1. Tuberculosis drug combined with virtual reality therapy is effective in treating fear of heights
2. Detrol LA combined with standard treatment for enlarged prostate is twice as effective
3. Nicotine more addictive when combined with other tobacco smoke chemicals, UCI study finds
4. Cognitive behavioral therapy combined with antidepressant effective in treating adolescent OCD
5. Heart disease kills more women annually than all cancers combined
6. Stents combined with clot-busting drugs effective in limiting impact of deadly form of stroke
7. Study shows people with Alzheimers can benefit from exercise combined with caregiver training
8. Wyeth chemists honored for Prevnar first combined pneumococcal vaccine for infants
9. Task force issues caution on combined hormone therapy
10. University of Pittsburgh research shows combined PET/CT finds cancerous lesions standard CT misses
11. Some patients are candidates for combined heart bypass, lung transplant surgeries

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2020)... ... 24, 2020 , ... Devcool Inc ( http://www.devcool.com ), ... completed its spin-off of HiPaaS, Inc ( http://www.hipaas.com ). HiPaaS Inc will ... its growth and focuses on Healthcare consulting services. , With HiPaaS, companies ...
(Date:1/24/2020)... (PRWEB) , ... January 24, 2020 , ... ... global consulting firm for the life sciences and food industries, is pleased to ... Specialist, at their head office and research site in Toronto, Canada. , Dr. ...
(Date:1/23/2020)... ... ... The Mount Sinai Health System has once again been ranked among America’s ... ranked No. 3 in the “Healthcare & Social” category and No. 19 overall among ... largest academic medical system, including eight hospitals, a leading medical school, and a vast ...
(Date:1/23/2020)... ... 2020 , ... The American Heart Association (AHA), the leading voluntary health organization ... County Go Red for Women Luncheon will take place Friday, February 21, 2020, ... residents are anticipated to attend the premier event designed to raise awareness and funds ...
(Date:1/23/2020)... ... January 23, 2020 , ... SignatureCare Emergency Center is set to expand ... TX . , Located in the heart of Lewisville, on 1596 W. Main St., ... nurses and experienced support staff. , It will serve residents and businesses around ...
Breaking Medicine News(10 mins):
(Date:1/12/2020)... ... January 10, 2020 , ... ... Remo Moomiaie-Qajar, MD has been selected to present at next week’s Biotech ... a vast platform with its proprietary Cargocyte™ next generation Adoptive Cellular Therapy ...
(Date:1/10/2020)... (PRWEB) , ... January 10, 2020 , ... ... and the American School Counselor Association, will celebrate high school counselors and award ... the College Football Playoff National Championship weekend and Extra Yard for Teachers Summit ...
(Date:1/10/2020)... ... January 10, 2020 , ... Myant Inc ... Las Vegas and showcasing a system of connected performance apparel (including a ... their bodies, their training partners and coaches. Connected fitness represents just one facet ...
Breaking Medicine Technology:
Cached News: